Long-Term Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing’s Disease: Interim Results From a Long-Term Real-World Evidence Study
Pituitary - Netherlands
doi 10.1007/s11102-019-00984-6
Full Text
Open PDFAbstract
Available in full text
Date
August 22, 2019
Authors
Publisher
Springer Science and Business Media LLC